Search

everythinglearnresearchcommunity

for

Search:↓

Giving a special protein to dogs with a certain genetic disease improved their symptoms but didn't help with hair growth.

Notch/CSL signaling controls hair follicle differentiation through Wnt5a and FoxN1.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Activin helps skin growth and healing mainly through stromal cells and affects keratinocytes based on its amount.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

FLRG and follistatin have different roles in wound healing.

α3β1-integrin is crucial for maintaining normal hair follicle shape and function but not needed for the development of the surrounding skin.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Leptin, a hormone, is important for starting hair growth.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

AGA linked to worse COVID-19 outcomes in men.

Prominin-1 expressing cells in the dermal papilla help regulate hair follicle size and communication but don't aid in skin repair.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Cetuximab can cause eyelash growth, which is rare but manageable.

Activin activation in skin cells speeds up wound healing without affecting scar quality.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Hedgehog signaling is crucial for mammary gland development over hair follicles.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.